Allakos Inc.(ALLK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALLK Allakos Inc.

Halted 12-05 16:57:46 EST

0.3291

+0.0000

0.00%

High0.3291	Low0.3291	Vol0.00
Open0.3291	D1 Closing0.3291	Amplitude0.00%
Mkt Cap29.74M	Tradable Cap17.11M	Total Shares90.38M
T/O238.63K	T/O Rate0.00%	Tradable Shares51.98M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALLK","market":"US","secType":"STK","nameCN":"Allakos Inc.","latestPrice":0.3291,"timestamp":1747252800000,"preClose":0.3291,"halted":3,"volume":0,"delay":0,"floatShares":51975859,"shares":90376972,"eps":-0.79384,"marketStatus":"Halted","change":0,"latestTime":"12-05 16:57:46 EST","open":0.3291,"high":0.3291,"low":0.3291,"amount":238626.81212786998,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.79384,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1531972800000,"exchange":"NASDAQ","adjPreClose":0.3291,"volumeRatio":0},"requestUrl":"/m/hq/s/ALLK","defaultTab":"news","newsList":[{"id":"2535232998","title":"Allakos Inc. Faces Delisting Notice Following Merger with Concentra Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2535232998","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535232998?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:16","pubTimestamp":1747315003,"startTime":"0","endTime":"0","summary":"Allakos Inc. announced a regulatory development concerning its listing status following the completion of a merger with Concentra Biosciences, LLC. As part of the merger consummation, Allakos requested The Nasdaq Global Select Market to suspend trading of its shares effective before the market opened on May 15, 2025. Additionally, the company requested Nasdaq to file a Notification of Removal from Listing to delist all its shares and deregister them under Section 12 of the Securities Exchange Act of 1934. Furthermore, the Surviving Corporation plans to file a Certification and Notice of Termination of Registration with the SEC, aiming to terminate the registration of its shares under Section 12 of the Exchange Act.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL3c6bns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLK","BK4185","BK4139","CON"],"gpt_icon":0},{"id":"2533993593","title":"Allakos Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533993593","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533993593?lang=en_us&edition=fundamental","pubTime":"2025-05-08 06:12","pubTimestamp":1746655967,"startTime":"0","endTime":"0","summary":"Allakos Inc reports results for the quarter ended March 31 - Earnings SummaryAllakos Inc ALLK.OQ reported a quarterly adjusted loss of 29 cents per share for the quarter ended March 31, higher than th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL8N3RF3HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLK"],"gpt_icon":0},{"id":"2533404585","title":"Allakos Inc  expected to post a loss of 29 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533404585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533404585?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:58","pubTimestamp":1746446284,"startTime":"0","endTime":"0","summary":"Allakos Inc  expected to post a loss of29cents a share - Earnings Preview Allakos Inc ALLK.OQ ALLK.O is expected to show no change in quarterly revenue when it reports  results on May 7 (estimated) fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD0T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLK"],"gpt_icon":0},{"id":"2524554419","title":"BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2524554419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524554419?lang=en_us&edition=fundamental","pubTime":"2025-04-03 00:33","pubTimestamp":1743611610,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO GroupEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nL3N3QG12P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","NCNO","SG9999015952.SGD","CME","LU1674673691.USD","IE00BGHQF748.EUR","RJF","LU0052756011.USD","CRBG","PARA","TSYW.SI","UAL","ALLK","CMA","EWTX","TKO","CNP","WSBC","GLSI","LU2326559502.SGD","RKT","MPTI","IDA","SAM","LGL","LU0742537680.HKD","RIOT","TFC","STR","TCBX","LU0130102774.USD","BECN","HUT","TRUMP.USD.CC","BK4077","WTF","SCHW","SSB","NCLH","WOOF","TAP","WBS"],"gpt_icon":1},{"id":"2524450499","title":"Allakos Inc Shares Rise 44.8% to 31 Cents on Buyout Deal With Concentra Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2524450499","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524450499?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:31","pubTimestamp":1743600710,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QG0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2524964034","title":"BUZZ-Allakos soars on buyout deal with Concentra Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2524964034","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524964034?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:21","pubTimestamp":1743600088,"startTime":"0","endTime":"0","summary":"BUZZ-Allakos soars on buyout deal with Concentra Biosciences** Shares of drug developer Allakos ALLK.O rise 45.6% to 32 cents premarket** Concentra Biosciences will buy Allakos for 33 cents per share in cash, a premium of 52% to ALLK's last close ** Allakos says a wholly owned subsidiary of Concentra will commence a tender offer by April 15 to acquire all outstanding shares of ALLK **  Co expects the deal to close in May 2025  ** Says closing of the deal is subject to availability of at least $35.5 million of cash at closing, and other customary closing conditions ** Shares of the company have fallen 82.1% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nL6N3QG0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2524493707","title":"Allakos to Be Acquired by Concentra Biosciences for $0.33 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2524493707","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524493707?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:55","pubTimestamp":1743598516,"startTime":"0","endTime":"0","summary":"Allakos  shares were over 45% higher in recent premarket trading Wednesday after the company said it has entered into a definitive agreement to be acquired by Concentra Biosciences.Under the merger agreement, a Concentra subsidiary will start a tender offer to acquire all outstanding shares of Allakos for $0.33 per share in cash by April 15.The transaction is expected to close in May, Allakos said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2524498251","title":"Allakos to Be Acquired for 33 Cents a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2524498251","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524498251?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:35","pubTimestamp":1743597300,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company Allakos, which early this year pulled the plug on its lead program and slashed its workforce by 75%, has struck a deal to be acquired for about $30 million.Allakos on Wednesday said Concentra Biosciences, controlled by life sciences-focused investment firm Tang Capital, has agreed to pay 33 cents a share in cash for the Menlo Park, Calif., company, a 52% premium to Tuesday's closing price of 21.7 cents.The deal is slated to close in May.Allakos shares collapsed in late January after the company said it was ending further development of AK006, its most advanced product candidate, following the failure of the drug in a phase 1 study in the skin condition chronic spontaneous urticaria.Trading in shares of Allakos was halted premarket on Wednesday. The stock traded as low as 21.6 cents during Tuesday's session, its lowest level since the company went public in 2018.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Allakos to Be Acquired for 33 Cents a Share","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2524446737","title":"BRIEF-Allakos Inc. Enters Into Agreement To Be Acquired By Concentra Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2524446737","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524446737?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:04","pubTimestamp":1743595457,"startTime":"0","endTime":"0","summary":"BRIEF-Allakos Inc. Enters Into Agreement To Be Acquired By Concentra BiosciencesApril 2 (Reuters) - Allakos Inc ALLK.O:ALLAKOS INC. ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES, LLC F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nTUA8XSTHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLK"],"gpt_icon":0},{"id":"2524627074","title":"Allakos Inc. Enters Into Agreement to Be Acquired by Concentra Biosciences, Llc for $0.33 in Cash per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2524627074","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524627074?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:00","pubTimestamp":1743595200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nTUA8XSTHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLK","BK4139"],"gpt_icon":0},{"id":"2518924486","title":"Allakos Inc  expected to post a loss of 17 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2518924486","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518924486?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:01","pubTimestamp":1741604517,"startTime":"0","endTime":"0","summary":"Allakos Inc  expected to post a loss of17cents a share - Earnings Preview Allakos Inc ALLK.OQ ALLK.O is expected to show no change in quarterly revenue when it reports  results on March 12 (estimated)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL8N3PT0LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLK"],"gpt_icon":0},{"id":"2506461586","title":"Sector Update: Health Care Stocks Gain Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2506461586","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506461586?lang=en_us&edition=fundamental","pubTime":"2025-01-28 03:10","pubTimestamp":1738005007,"startTime":"0","endTime":"0","summary":"Health care stocks rose Monday afternoon, with the NYSE Health Care Index adding 2% and the Health Care Select Sector SPDR Fund  up 2.1%.The iShares Biotechnology ETF  rose 0.7%.In corporate news, Walgreens Boots Alliance  shares fell 6.4% after CNBC's David Faber reported the company's talks with Sycamore Partners on a go-private deal are \"mostly dead,\" according to media reports.Sage Therapeutics  said Monday its board rejected Biogen's  unsolicited, non-binding proposal to buy Sage shares not already owned by Biogen for $7.22 per share. Sage shares rose 4.8% and Biogen was adding 1.8%.Allakos  said Monday its phase 1 trial of AK006 in chronic spontaneous urticaria failed to demonstrate therapeutic efficacy and that its development will be terminated immediately. Its shares dropped 78%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00B19Z9P08.USD","WBA.AU","WBA","IBB","BK4581","BK4588","LU0320765992.SGD","BK4532","BK4533","LU0109394709.USD","BK4128","LU0321505439.SGD","LU0889565916.HKD","BK4139","ALLK","LU0321505868.SGD","LU0234570918.USD","XLV","BIIB","IE00B894F039.SGD","SAGE","IE00B19Z9Z06.USD"],"gpt_icon":0},{"id":"2506586505","title":"S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2506586505","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506586505?lang=en_us&edition=fundamental","pubTime":"2025-01-28 02:56","pubTimestamp":1738004212,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/43245892/sp-500-falls-over-100-points-dada-nexus-shares-spike-higher","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","BK4155","BK4579","BK4139","JD","ELAB","NVIW.SI","QID","USAW.SI","BK4509","BK4588","BK4531","NQmain","LU0106959298.USD","BK4183","BK4526","BK4584","BK4023","BK4557","TQQQ","ALLK","IE00BGV7N243.SGD","LU1188198961.HKD","VERU","LU0244354667.USD","SQQQ","USJW.SI","09618",".IXIC","BK4504","MNQmain","JG","TSYW.SI","BK4587","LU1880383366.USD","PSQ",".SPX","QLD","LU0326950275.SGD","DADA","LU1688375341.USD","BK4563","SPY","AKRO","BK4505","PCOM","BK4551","VOO","BK4585"],"gpt_icon":1},{"id":"2506309849","title":"Allakos Shares Plummet to All-Time Low After Lead Candidate Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506309849?lang=en_us&edition=fundamental","pubTime":"2025-01-27 23:23","pubTimestamp":1737991380,"startTime":"0","endTime":"0","summary":"Allakos shares collapsed on Monday after the clinical-stage biotechnology company threw in the towel on its AK006 product candidate and said it would slash its workforce by 75%.Shares of Allakos were recently down 77% to 27 cents, changing hands at their lowest level since the San Carlos, Calif., company went public in 2018.Allakos said it is ending further development of AK006, its most advanced product candidate, after the drug didn't show therapeutic activity in a Phase 1 study in the skin condition chronic spontaneous urticaria.Allakos said it plans to explore strategic alternatives, adding that it expects its cash, equivalents and investments will total $35 million to $40 million by the end of June. The company now sports a market capitalization of around $24 million after the steep drop in its share price.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLK","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allakos.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.7062},{"period":"ytd","weight":-0.728}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.327082},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.038519},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.127593},{"month":4,"riseRate":0.285714,"avgChangeRate":0.039802},{"month":5,"riseRate":0.428571,"avgChangeRate":0.012232},{"month":6,"riseRate":0.5,"avgChangeRate":-0.038115},{"month":7,"riseRate":0.5,"avgChangeRate":-0.009175},{"month":8,"riseRate":0.571429,"avgChangeRate":0.233613},{"month":9,"riseRate":0.428571,"avgChangeRate":0.016479},{"month":10,"riseRate":0.428571,"avgChangeRate":0.110399},{"month":11,"riseRate":0.714286,"avgChangeRate":0.129817},{"month":12,"riseRate":0.714286,"avgChangeRate":-0.035834}],"exchange":"NASDAQ","name":"Allakos Inc.","nameEN":"Allakos Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allakos Inc.(ALLK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Allakos Inc.(ALLK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Allakos Inc.,ALLK,Allakos Inc.股票,Allakos Inc.股票老虎,Allakos Inc.股票老虎国际,Allakos Inc.行情,Allakos Inc.股票行情,Allakos Inc.股价,Allakos Inc.股市,Allakos Inc.股票价格,Allakos Inc.股票交易,Allakos Inc.股票购买,Allakos Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allakos Inc.(ALLK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Allakos Inc.(ALLK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction